| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: RN given refers to cpd without isomeric designation; structure
Also Known As:| 1. | Sarcoma (Soft Tissue Sarcoma)
05/01/1976
- "A comparison was made of the action of sarcolysin and asalin on the synthesis of DNA in sarcoma 45, the spleen, thymus, bone marrow and liver of tumour-bearing rats depending of the time of administration of the preparation. "
05/01/1976 - "[Effect of sarcolysin and asalin on the incorporation of thymidine-H3 in the DNA of sarcoma 45 and tissues of tumor-bearing rats]" 11/01/1969 - "[Regression of rat sarcoma 45 at single administration of sarcolysine, asalin and asalei]" Order ALL the reference details at left... |
| 2. | Neoplasms (Cancer)
05/01/1976
- "[Effect of sarcolysin and asalin on the incorporation of thymidine-H3 in the DNA of sarcoma 45 and tissues of tumor-bearing rats]"
Order ALL the reference details at left... |
| 1. | Melphalan (Alkeran)
|
| 2. | DNA (Deoxyribonucleic Acid)
|
| 3. | leucine sarcolysine
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |